DEXCOM INC (DXCM) Fundamental Analysis & Valuation

NASDAQ:DXCM • US2521311074

Current stock price

64.78 USD
-1.02 (-1.55%)
Last:

This DXCM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. DXCM Profitability Analysis

1.1 Basic Checks

  • DXCM had positive earnings in the past year.
  • In the past year DXCM had a positive cash flow from operations.
  • DXCM had positive earnings in each of the past 5 years.
  • DXCM had a positive operating cash flow in each of the past 5 years.
DXCM Yearly Net Income VS EBIT VS OCF VS FCFDXCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • The Return On Assets of DXCM (13.19%) is better than 94.15% of its industry peers.
  • With an excellent Return On Equity value of 30.46%, DXCM belongs to the best of the industry, outperforming 97.34% of the companies in the same industry.
  • DXCM has a better Return On Invested Capital (18.92%) than 96.81% of its industry peers.
  • DXCM had an Average Return On Invested Capital over the past 3 years of 14.59%. This is significantly above the industry average of 9.40%.
  • The 3 year average ROIC (14.59%) for DXCM is below the current ROIC(18.92%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.19%
ROE 30.46%
ROIC 18.92%
ROA(3y)10.24%
ROA(5y)8.29%
ROE(3y)28.01%
ROE(5y)22.13%
ROIC(3y)14.59%
ROIC(5y)11.66%
DXCM Yearly ROA, ROE, ROICDXCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 30

1.3 Margins

  • With an excellent Profit Margin value of 17.94%, DXCM belongs to the best of the industry, outperforming 93.62% of the companies in the same industry.
  • In the last couple of years the Profit Margin of DXCM has declined.
  • DXCM has a better Operating Margin (21.55%) than 93.62% of its industry peers.
  • In the last couple of years the Operating Margin of DXCM has grown nicely.
  • Looking at the Gross Margin, with a value of 62.09%, DXCM is in the better half of the industry, outperforming 65.43% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DXCM has declined.
Industry RankSector Rank
OM 21.55%
PM (TTM) 17.94%
GM 62.09%
OM growth 3Y15.68%
OM growth 5Y5.09%
PM growth 3Y15.23%
PM growth 5Y-8.86%
GM growth 3Y-1.61%
GM growth 5Y-1.72%
DXCM Yearly Profit, Operating, Gross MarginsDXCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. DXCM Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DXCM is creating value.
  • Compared to 1 year ago, DXCM has less shares outstanding
  • The number of shares outstanding for DXCM remains at a similar level compared to 5 years ago.
  • DXCM has a better debt/assets ratio than last year.
DXCM Yearly Shares OutstandingDXCM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
DXCM Yearly Total Debt VS Total AssetsDXCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 6.38 indicates that DXCM is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.38, DXCM belongs to the top of the industry, outperforming 81.91% of the companies in the same industry.
  • DXCM has a debt to FCF ratio of 1.20. This is a very positive value and a sign of high solvency as it would only need 1.20 years to pay back of all of its debts.
  • DXCM's Debt to FCF ratio of 1.20 is amongst the best of the industry. DXCM outperforms 89.89% of its industry peers.
  • A Debt/Equity ratio of 0.47 indicates that DXCM is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.47, DXCM is in line with its industry, outperforming 43.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1.2
Altman-Z 6.38
ROIC/WACC2.26
WACC8.38%
DXCM Yearly LT Debt VS Equity VS FCFDXCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • DXCM has a Current Ratio of 1.88. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.88, DXCM is not doing good in the industry: 65.96% of the companies in the same industry are doing better.
  • DXCM has a Quick Ratio of 1.59. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
  • DXCM has a Quick ratio (1.59) which is in line with its industry peers.
  • DXCM does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.59
DXCM Yearly Current Assets VS Current LiabilitesDXCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. DXCM Growth Analysis

3.1 Past

  • DXCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.73%, which is quite good.
  • The Earnings Per Share has been growing by 19.29% on average over the past years. This is quite good.
  • The Revenue has grown by 15.60% in the past year. This is quite good.
  • The Revenue has been growing by 19.33% on average over the past years. This is quite good.
EPS 1Y (TTM)12.73%
EPS 3Y28.82%
EPS 5Y19.29%
EPS Q2Q%0%
Revenue 1Y (TTM)15.6%
Revenue growth 3Y17.01%
Revenue growth 5Y19.33%
Sales Q2Q%13.12%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.71% on average over the next years. This is a very strong growth
  • DXCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.94% yearly.
EPS Next Y36.69%
EPS Next 2Y27.75%
EPS Next 3Y24.99%
EPS Next 5Y21.71%
Revenue Next Year12.62%
Revenue Next 2Y12.47%
Revenue Next 3Y12.38%
Revenue Next 5Y11.94%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DXCM Yearly Revenue VS EstimatesDXCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
DXCM Yearly EPS VS EstimatesDXCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. DXCM Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 34.83 indicates a quite expensive valuation of DXCM.
  • DXCM's Price/Earnings ratio is a bit cheaper when compared to the industry. DXCM is cheaper than 71.28% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of DXCM to the average of the S&P500 Index (26.91), we can say DXCM is valued slightly more expensively.
  • The Price/Forward Earnings ratio is 25.48, which means the current valuation is very expensive for DXCM.
  • 74.47% of the companies in the same industry are more expensive than DXCM, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of DXCM to the average of the S&P500 Index (23.69), we can say DXCM is valued inline with the index average.
Industry RankSector Rank
PE 34.83
Fwd PE 25.48
DXCM Price Earnings VS Forward Price EarningsDXCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DXCM is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DXCM indicates a rather cheap valuation: DXCM is cheaper than 84.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.14
EV/EBITDA 18.74
DXCM Per share dataDXCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • DXCM has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as DXCM's earnings are expected to grow with 24.99% in the coming years.
PEG (NY)0.95
PEG (5Y)1.81
EPS Next 2Y27.75%
EPS Next 3Y24.99%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DXCM Dividend Analysis

5.1 Amount

  • DXCM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DXCM Fundamentals: All Metrics, Ratios and Statistics

DEXCOM INC

NASDAQ:DXCM (4/9/2026, 9:37:07 AM)

64.78

-1.02 (-1.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)04-30
Inst Owners100.29%
Inst Owner Change0.01%
Ins Owners0.2%
Ins Owner Change9.44%
Market Cap24.93B
Revenue(TTM)4.66B
Net Income(TTM)836.30M
Analysts84.86
Price Target88.6 (36.77%)
Short Float %4.26%
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.4%
Min EPS beat(2)-32.12%
Max EPS beat(2)5.32%
EPS beat(4)2
Avg EPS beat(4)-6.03%
Min EPS beat(4)-32.12%
Max EPS beat(4)6.77%
EPS beat(8)5
Avg EPS beat(8)-1.11%
EPS beat(12)9
Avg EPS beat(12)9.15%
EPS beat(16)11
Avg EPS beat(16)5.86%
Revenue beat(2)1
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-0.9%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-0.9%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-1.02%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)6
Avg Revenue beat(16)-0.53%
PT rev (1m)0.3%
PT rev (3m)0.07%
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)-0.14%
EPS NY rev (1m)0%
EPS NY rev (3m)0.83%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 34.83
Fwd PE 25.48
P/S 5.35
P/FCF 23.14
P/OCF 17.3
P/B 9.08
P/tB 9.4
EV/EBITDA 18.74
EPS(TTM)1.86
EY2.87%
EPS(NY)2.54
Fwd EY3.92%
FCF(TTM)2.8
FCFY4.32%
OCF(TTM)3.74
OCFY5.78%
SpS12.11
BVpS7.14
TBVpS6.89
PEG (NY)0.95
PEG (5Y)1.81
Graham Number17.28
Profitability
Industry RankSector Rank
ROA 13.19%
ROE 30.46%
ROCE 23.93%
ROIC 18.92%
ROICexc 36.12%
ROICexgc 37.75%
OM 21.55%
PM (TTM) 17.94%
GM 62.09%
FCFM 23.11%
ROA(3y)10.24%
ROA(5y)8.29%
ROE(3y)28.01%
ROE(5y)22.13%
ROIC(3y)14.59%
ROIC(5y)11.66%
ROICexc(3y)37.89%
ROICexc(5y)31.72%
ROICexgc(3y)41.79%
ROICexgc(5y)35.48%
ROCE(3y)18.46%
ROCE(5y)14.75%
ROICexgc growth 3Y1.89%
ROICexgc growth 5Y6.96%
ROICexc growth 3Y7.33%
ROICexc growth 5Y6.44%
OM growth 3Y15.68%
OM growth 5Y5.09%
PM growth 3Y15.23%
PM growth 5Y-8.86%
GM growth 3Y-1.61%
GM growth 5Y-1.72%
F-Score8
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1.2
Debt/EBITDA 1.03
Cap/Depr 144.36%
Cap/Sales 7.8%
Interest Coverage 88.12
Cash Conversion 114.67%
Profit Quality 128.81%
Current Ratio 1.88
Quick Ratio 1.59
Altman-Z 6.38
F-Score8
WACC8.38%
ROIC/WACC2.26
Cap/Depr(3y)145.46%
Cap/Depr(5y)210.39%
Cap/Sales(3y)7.74%
Cap/Sales(5y)10.33%
Profit Quality(3y)110.93%
Profit Quality(5y)89.33%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y28.82%
EPS 5Y19.29%
EPS Q2Q%0%
EPS Next Y36.69%
EPS Next 2Y27.75%
EPS Next 3Y24.99%
EPS Next 5Y21.71%
Revenue 1Y (TTM)15.6%
Revenue growth 3Y17.01%
Revenue growth 5Y19.33%
Sales Q2Q%13.12%
Revenue Next Year12.62%
Revenue Next 2Y12.47%
Revenue Next 3Y12.38%
Revenue Next 5Y11.94%
EBIT growth 1Y53.73%
EBIT growth 3Y35.36%
EBIT growth 5Y25.41%
EBIT Next Year68.67%
EBIT Next 3Y32.44%
EBIT Next 5Y25.77%
FCF growth 1Y70.79%
FCF growth 3Y52.34%
FCF growth 5Y31.25%
OCF growth 1Y45.6%
OCF growth 3Y29.1%
OCF growth 5Y24.81%

DEXCOM INC / DXCM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DEXCOM INC?

ChartMill assigns a fundamental rating of 7 / 10 to DXCM.


What is the valuation status of DEXCOM INC (DXCM) stock?

ChartMill assigns a valuation rating of 6 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.


What is the profitability of DXCM stock?

DEXCOM INC (DXCM) has a profitability rating of 8 / 10.


How financially healthy is DEXCOM INC?

The financial health rating of DEXCOM INC (DXCM) is 8 / 10.